Back
ImmunoPrecise Antibodies Stock Predictions
Sponsored
IPA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
IPA
ImmunoPrecise Antibodies
Last Price:
0.36
Seasonality Move:
4.89%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.ImmunoPrecise Antibodies Stock Forecast
-
Is ImmunoPrecise Antibodies Stock Undervalued?
The current ImmunoPrecise Antibodies [IPA] share price is $0.35. The Score for IPA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal. - IPA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will ImmunoPrecise Antibodies Stock Go Up Next Year?
Data Unavailable
ImmunoPrecise Antibodies Stock Rating
Data Unavailable
ImmunoPrecise Antibodies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Canada
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
ipatherapeutics.com
52-Week Data
52-Week High:
2.60
52-Week Low:
0.32
Prediction Charts
Market Cap:
9.73M
Price in USD:
0.35
Volume:
385.77K
Beta:
-0.38
Technical Analysis
SMA50:
0.55
SMA100:
0.69
SMA200:
1.04
52-Wk Change:
-72.99%
Stock Predictions
-
Is ImmunoPrecise Antibodies stock public?
Yes, ImmunoPrecise Antibodies is a publicly traded company. -
What is the ImmunoPrecise Antibodies stock quote today?
The ImmunoPrecise Antibodies stock price is 0.35 USD today. -
How to buy ImmunoPrecise Antibodies stock online?
You can buy ImmunoPrecise Antibodies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-4 | 0.42 | 0.43 | 0.46 | 0.42 |
Nov-5 | 0.42 | 0.42 | 0.45 | 0.40 |
Nov-6 | 0.40 | 0.39 | 0.41 | 0.35 |
Nov-7 | 0.39 | 0.44 | 0.46 | 0.39 |
Nov-8 | 0.44 | 0.44 | 0.47 | 0.43 |
Nov-11 | 0.43 | 0.45 | 0.45 | 0.42 |
Nov-12 | 0.44 | 0.47 | 0.48 | 0.44 |
Nov-13 | 0.53 | 0.48 | 0.53 | 0.40 |
Nov-14 | 0.49 | 0.46 | 0.49 | 0.42 |
Nov-15 | 0.46 | 0.44 | 0.46 | 0.43 |
Nov-18 | 0.44 | 0.41 | 0.48 | 0.39 |
Nov-19 | 0.40 | 0.41 | 0.41 | 0.38 |
Nov-20 | 0.41 | 0.39 | 0.41 | 0.37 |
Nov-21 | 0.38 | 0.35 | 0.42 | 0.32 |
ImmunoPrecise Antibodies Earnings
Data Unavailable
ImmunoPrecise Antibodies Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.09 per share.
* ImmunoPrecise Antibodies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.